Brii Licenses BRII-693 Rights in Greater China to Joincare Group
03 Jul 2025 //
PR NEWSWIRE
TaiGen’s partner, Joincare completes influenza antiviral TG-1000 phase III study
19 Apr 2024 //
PHARMABIZ
03 Jul 2025 //
PR NEWSWIRE
19 Apr 2024 //
PHARMABIZ